Skip to main content
Enjaymo 50 mg/mL injection, solution, concentrate by Recordati Rare Diseases, Inc.
Enjaymo, 50 mg/mL, injection, solution, concentrate Drug class: Classical Complement Pathway Inhibitor. Available on prescription only. Listed by Recordati Rare Diseases, Inc..
Prescription only

Enjaymo

sutimlimab-jome

Listed by Recordati Rare Diseases, Inc.

Strength
50 mg/mL
Form
Injection, Solution, Concentrate
Route
Intravenous
Class
Classical Complement Pathway Inhibitor

What it contains

  • Sutimlimab 50 mg/mL

FDA record

Dosage form Injection, Solution, Concentrate
Route Intravenous
Drug class Classical Complement Pathway Inhibitor
Approval route BLA — biologic licence
NDC code 55292-820
FDA application BLA761164
RxNorm concept 2591419
Package sizes listed 1
Marketed since February 2022

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.